WHO ICTRP trial
Comparing two medicines ivabradine and esmolol in their effectiveness for…
CTRI/2025/12/099041 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/12/099041 |
|---|---|
| Public title | Comparing two medicines ivabradine and esmolol in their effectiveness for achieving heart rate control in patients with severe infection. |
| Scientific title | Heart rate control with Ivabradine vs Esmolol for RefrActoRy taCHYcardia in Septic Shock A randomized controlled trial. - HIERARCHY-SS |
| Primary sponsor | Dept of Anaesthesiology, Pain Medicine and Critical Care |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: B998- Other infectious disease |
| Interventions | Intervention1: IVABRADINE: Ivabradine tablet will be administered orally in patients who are able to swallow, or crushed and administered through Ryle s tube, every 12 hours. The dose of ivabradine will be adjusted depending on heart rate… |
| Registration date | Dec 15, 2025 |
| Target size | 260 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: